Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 December 2021 | Story Nondsindiso Qwabe | Photo Supplied
Bachelor of Education third-year student, Moeketsi ‘Escalator’ Ngesemane.

By day he is a third-year Bachelor of Education student on the Qwaqwa Campus, but this young man is a Sesotho music maestro with a deep-rooted passion for traditional music and a diligent devotion to unearthing new talent and connecting more people to the cultural artistry that Sesotho music has to offer.

Moeketsi Ngesemane, better known as ‘Escalator’ in the world of music, is only 22 years old, but he has already released one solo album and featured in two more, leads a group of more than 80 traditional singers and dancers, and is responsible for a string of groups around Qwaqwa. He has made strides far beyond his age, and Ngesemane says he is only getting started. He was also instrumental in coordinating the Qwaqwa traditional groups that performed during this year’s Multilingual Mokete festival, where he also featured.

Born and bred in Qwaqwa, Ngesemane pins his love for traditional music as something that was cultivated in his childhood while singing traditional songs with his mother and brother. “My mother is a traditional healer, so Sesotho music was a big part of my upbringing. As I grew older, my brother and I would perform in town and people would give us money. I have not looked back since.”

He cemented himself as an artist and artist manager in his first year in 2009. The name ‘Escalator’ came about in an uncanny way, as he fondly recalls. “I had a friend who was afraid of escalators when he first saw it – but I wasn’t, so he named me ‘Escalator’. I hated the name until I personalised the meaning behind it. It is able to take people from one point to another and from one level to another, which is something I am passionate about doing through traditional music, so the name was fitting.”

He captivated the minds and hearts of both young and old people who want to be under his leadership, and he grooms young people as young as ten, who will also thrive and take traditional praise singing and dancing to greater heights. This, he says, helps him alleviate some responsibilities so that he can focus on his schoolwork.

Celebrating the Sesotho culture through music

Word about his music skill often spreads quickly. “Even when I am on teaching practicals at different schools, once learners find out what I do, they ask to join my group and I can’t say no. Their ages range from 7 to 21, and I know that my group will have more than 100 members before the year ends,” he said.

He often puts together music shows with his group around Qwaqwa. This, he says, he does to promote Sesotho music and art.

Ngesemane has been selected to represent the Basotho Kingdom at the Indoni Mr and Miss Cultural South Africa – an indigenous event focused on promoting South Africa’s diverse cultural heritage, taking place at the Durban ICC on 17 December. He describes this as a dream come true.

“It’s a great honour to be representing the Basotho culture. I have discovered that young people, especially, have neglected their cultural roots and often look down on traditional music and regalia. I’ve made it my personal aim to promote and uphold the Sesotho culture through praise singing and dancing.”

You can vote for Ngesemane by SMS’ing ‘Indoni Mr Sotho’ to 33616.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept